VENEE TUBMAN to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications VENEE TUBMAN has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.657
-
Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel. Ann Hematol. 2024 Jun; 103(6):1909-1917.
Score: 0.657